finance.yahoo.com Regulatory and legal
Becton Dickinson (BDX) Completes PREVENT Trial Enrollment For Hernia Prevention Mesh
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Becton Dickinson (NYSE:BDX) reported completion of patient enrollment in its PREVENT clinical trial evaluating Phasix Mesh for prevention of incisional hernias. The large scale study is designed to assess the safety and effectiveness of Phasix Mesh as a prophylactic …